Mr. Kevin Brian Davidson, M.A., L.P.A. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1309 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-933-3212 Fax: 704-933-3221 |
John Allmond, PSYD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 4949 Professional Park Dr, Ste 101, Kannapolis, NC 28081 Phone: 704-938-6521 |
Robert C Werstlein, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1305 S Cannon Blvd, Kannapolis, NC 28083 Phone: 704-939-1100 Fax: 704-939-1173 |
Mrs. Sarah B Fishback, MA Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 1605 Old Earnhardt Rd, Kannapolis, NC 28083 Phone: 704-933-5305 |
News Archive
Scientists have discovered two "body clock" genes that reveal how seasonal changes in hormones are controlled and could ultimately help find treatments for seasonal affective disorder.
The ADEAGies Foundation, the philanthropic arm of the American Dental Education Association, has selected Columbia University's College of Dental Medicine for a 2014 William J. Gies Award, for outstanding achievement by an academic dental institution in support of dental education. The award recognizes CDM's Community DentCare program, which provides low- or no-cost dental care to children, adults, and seniors in Northern Manhattan and the Bronx.
Patients with malignant melanoma - whose disease has spread - are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool.
Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that although venous procedures are set to grow by more than 10% through 2013, a lack of awareness among referring physicians is a major roadblock in increased interventions in the venous system.
Cell Therapeutics, Inc. and Chroma Therapeutics Ltd. announced that final results from the phase II OPAL study of tosedostat in elderly patients with relapsed or refractory acute myeloid leukemia (AML) were presented by Jorge Cortes, M.D. of the University of Texas M.D. Anderson Cancer Center during the Acute Myeloid Leukemia - Therapy, excluding Transplantation: Clinical Studies session at the American Society of Hematology Annual Meeting.
› Verified 8 days ago